{
  "id": "binet_staging_cll",
  "title": "Binet Staging System for Chronic Lymphocytic Leukemia (CLL)",
  "description": "Stages chronic lymphocytic leukemia based on lymphadenopathy areas and hematologic parameters to predict prognosis and guide treatment decisions",
  "category": "hematology",
  "version": "1977",
  "parameters": [
    {
      "name": "cervical_lymphadenopathy",
      "type": "string",
      "required": true,
      "description": "Enlarged cervical lymph nodes (neck region)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": [
        "yes - Cervical lymphadenopathy present",
        "no - No cervical lymphadenopathy"
      ]
    },
    {
      "name": "axillary_lymphadenopathy", 
      "type": "string",
      "required": true,
      "description": "Enlarged axillary lymph nodes (underarm region)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": [
        "yes - Axillary lymphadenopathy present",
        "no - No axillary lymphadenopathy"
      ]
    },
    {
      "name": "inguinal_lymphadenopathy",
      "type": "string", 
      "required": true,
      "description": "Enlarged inguinal lymph nodes (groin region)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": [
        "yes - Inguinal lymphadenopathy present",
        "no - No inguinal lymphadenopathy"
      ]
    },
    {
      "name": "splenomegaly",
      "type": "string",
      "required": true,
      "description": "Enlarged spleen (splenomegaly)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": [
        "yes - Splenomegaly present", 
        "no - No splenomegaly"
      ]
    },
    {
      "name": "hepatomegaly",
      "type": "string",
      "required": true,
      "description": "Enlarged liver (hepatomegaly)",
      "validation": {
        "enum": ["yes", "no"]
      },
      "options": [
        "yes - Hepatomegaly present",
        "no - No hepatomegaly"
      ]
    },
    {
      "name": "hemoglobin",
      "type": "float",
      "required": true,
      "description": "Hemoglobin level in g/dL",
      "unit": "g/dL",
      "validation": {
        "min": 3.0,
        "max": 20.0
      }
    },
    {
      "name": "platelet_count",
      "type": "integer",
      "required": true,
      "description": "Platelet count in thousands per mm³ (×10³/mm³)",
      "unit": "×10³/mm³",
      "validation": {
        "min": 10,
        "max": 1000
      }
    }
  ],
  "result": {
    "name": "binet_stage",
    "type": "string",
    "unit": "stage",
    "description": "Binet staging classification for CLL prognosis"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 1,
        "max": 1,
        "stage": "Stage A",
        "description": "Low risk - <3 lymphoid areas involved, normal Hgb and platelets",
        "interpretation": "Low risk CLL with favorable prognosis. Estimated median overall survival: ~12 years. Most patients can be monitored with watchful waiting. Consider treatment only if disease progression or symptoms develop."
      },
      {
        "min": 2,
        "max": 2,
        "stage": "Stage B", 
        "description": "Intermediate risk - ≥3 lymphoid areas involved, normal Hgb and platelets",
        "interpretation": "Intermediate risk CLL with moderate prognosis. Estimated median overall survival: ~7 years. May require earlier treatment consideration. Monitor closely for disease progression and development of symptoms."
      },
      {
        "min": 3,
        "max": 3,
        "stage": "Stage C",
        "description": "High risk - Anemia (Hgb <10 g/dL) and/or thrombocytopenia (platelets <100×10³/mm³)",
        "interpretation": "High risk CLL with poor prognosis. Estimated median overall survival: 2-4 years. Typically requires immediate treatment consideration. Close monitoring and aggressive management indicated."
      }
    ]
  },
  "references": [
    "Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981 Jul 1;48(1):198-206.",
    "Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 Jun 21;131(25):2745-2760.",
    "Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975 Aug;46(2):219-34."
  ],
  "formula": "Count lymphoid areas involved (cervical, axillary, inguinal, spleen, liver). Stage A: <3 areas + normal Hgb/platelets. Stage B: ≥3 areas + normal Hgb/platelets. Stage C: Anemia (Hgb <10 g/dL) and/or thrombocytopenia (platelets <100×10³/mm³)",
  "notes": [
    "The Binet system is the European standard for CLL staging, comparable to the American Rai system",
    "Five lymphoid areas are assessed: cervical, axillary, inguinal lymph nodes, plus spleen and liver",
    "Anemia is defined as hemoglobin <10 g/dL (100 g/L)",
    "Thrombocytopenia is defined as platelet count <100×10³/mm³ (100×10⁹/L)",
    "Stage C has the worst prognosis regardless of number of lymphoid areas involved",
    "Modern molecular markers (17p deletion, TP53 mutations, IGHV status) provide additional prognostic information",
    "Survival estimates may be improved with modern targeted therapies",
    "Both Binet and Rai systems are simple, reproducible, and require only physical examination and basic labs",
    "Treatment decisions should incorporate clinical symptoms, performance status, and comorbidities"
  ]
}